Cargando…

Reduced Glutathione suppresses Oxidative Stress in Nonalcoholic Fatty Liver Disease

BACKGROUND AND AIMS: Insulin resistance and cytokine production are key mechanisms leading to fatty change in the liver and may produce nonalcoholic steatohepatitis (NASH). Oxidative stress may also contribute to clinical progression from simple fatty liver (FL) to NASH. A therapy for insulin resist...

Descripción completa

Detalles Bibliográficos
Autores principales:	Irie, Makoto, Sohda, Tetsuro, Anan, Akira, Fukunaga, Atsushi, Takata, Kazuhide, Tanaka, Takashi, Yokoyama, Keiji, Morihara, Daisuke, Takeyama, Yasuaki, Shakado, Satoshi, Sakisaka, Shotaro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Jaypee Brothers Medical Publishers 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578552/ https://www.ncbi.nlm.nih.gov/pubmed/29201718 http://dx.doi.org/10.5005/jp-journals-10018-1159

Ejemplares similares

The Rate of Referral of Hepatitis Virus Carriers to Hepatologists and the Factors Contributing to Referral
por: Takata, Kazuhide, et al.
Publicado: (2017)

Changes in the Serum Hepcidin-to-ferritin Ratio with Erythroferrone after Hepatitis C Virus Eradication Using Direct-acting Antiviral Agents
por: Inomata, Shinjiro, et al.
Publicado: (2019)

Male-specific Association between Iron and Lipid Metabolism Changes and Erythroferrone after Hepatitis C Virus Eradication
por: Inomata, Shinjiro, et al.
Publicado: (2021)

Combination therapy of lamivudine and adefovir in Japanese patients with chronic hepatitis B
por: Shakado, Satoshi, et al.
Publicado: (2008)

Hepatitis B Virus Reactivation after Receiving Cancer Chemotherapy under Administration of Leuprorelin Acetate
por: Yamauchi, Ryo, et al.
Publicado: (2020)

Hepatic Pseudolymphoma with an Occult Hepatitis B Virus Infection
por: Kunimoto, Hideo, et al.
Publicado: (2017)

Spontaneous rupture of metastatic α-fetoprotein-producing gastric cancer of the liver
por: Sohda, Tetsuro, et al.
Publicado: (2008)

Endoscopic treatment or balloon-occluded retrograde transvenous obliteration is safe for patients with esophageal/gastric varices in Child-Pugh class C end-stage liver cirrhosis
por: Yokoyama, Keiji, et al.
Publicado: (2019)

Multipolar radiofrequency ablation via three bipolar electrodes with C-arm type X-ray fluoroscopy assistance for hepatocellular carcinoma: An observational study
por: Tanaka, Takashi, et al.
Publicado: (2022)

Budd-Chiari Syndrome: Two Cases with Different Courses
por: Inomata, Shinjiro, et al.
Publicado: (2008)

Hepatocellular Carcinoma Arising in a Non-cirrhotic Liver with Secondary Hemochromatosis
por: Yamauchi, Ryo, et al.
Publicado: (2018)

Factors Attenuating Zinc Deficiency Improvement in Direct-Acting Antiviral Agent-Treated Chronic Hepatitis C Virus Infection
por: Ko, Yi-Ling, et al.
Publicado: (2018)

Two Cases of Hepatocellular Carcinoma Arising Over 20 Years after a Sustained Virologic Response Following Interferon Therapy for Chronic Hepatitis C
por: Takata, Kazuhide, et al.
Publicado: (2020)

Horizontal Transmission of Hepatitis B Virus Genotype C Among Members of a Wrestling Club in Japan
por: Takata, Kazuhide, et al.
Publicado: (2020)

Novel Endoscopic Therapy for Gastric Varices Using Direct Forward-Viewing Endoscopic Ultrasonography
por: Yokoyama, Keiji, et al.
Publicado: (2021)

Unresectable Ectopic Hepatocellular Carcinoma Treated with Sorafenib
por: Ko, Yi-Ling, et al.
Publicado: (2020)

Pretreatment Modified Albumin–Bilirubin Grade Is an Important Predictive Factor Associated with the Therapeutic Response and the Continuation of Atezolizumab plus Bevacizumab Combination Therapy for Patients with Unresectable Hepatocellular Carcinoma
por: Tanaka, Takashi, et al.
Publicado: (2022)

Malnutrition and inflammation status in nonobese patients with inflammatory bowel disease are associated with nonalcoholic fatty liver disease: a retrospective study
por: Nagata, Takahiro, et al.
Publicado: (2023)

Autoimmune Hepatitis with Concomitant Idiopathic Thrombocytopenic Purpura Diagnosed by Transjugular Liver Biopsy
por: Fukuda, Hiromi, et al.
Publicado: (2018)

Exploratory Research on the Relationship between Human Gut Microbiota and Portal Hypertension
por: Yokoyama, Keiji, et al.
Publicado: (2020)

Hepatitis B virus core–related antigen is useful for surveillance of hepatocellular carcinoma recurrence in a patient with occult hepatitis B virus infection: Case report
por: Yokoyama, Keiji, et al.
Publicado: (2020)

Gastroesophageal Varices and Hyperplastic Nodules of the Liver in a Patient with Anorexia Nervosa
por: Takata, Kazuhide, et al.
Publicado: (2021)

Long-term outcome and eligibility of radiofrequency ablation for hepatocellular carcinoma over 3.0 cm in diameter
por: Tanaka, Takashi, et al.
Publicado: (2023)

Two Cases of Rapidly Progressive Fatty Liver Disease due to Pancreatic Exocrine Insufficiency without a History of Surgery
por: Takata, Kazuhide, et al.
Publicado: (2023)

Eosinophilic Granuloma of the Liver Mimicking Metastatic Liver Tumor
por: Uchida, Yotaro, et al.
Publicado: (2021)

Magnetic resonance cholangiopancreatography for afferent loop syndrome
por: Takata, Kazuhide, et al.
Publicado: (2019)

Long-Term Effects of Rifaximin on Patients with Hepatic Encephalopathy: Its Possible Effects on the Improvement in the Blood Ammonia Concentration Levels, Hepatic Spare Ability and Refractory Ascites
por: Yokoyama, Keiji, et al.
Publicado: (2022)

Familial Primary Biliary Cholangitis With Different Clinical Courses Based on Anti-gp210 Antibody Positivity: A Report of Two Cases
por: Nagata, Takahiro, et al.
Publicado: (2023)

Pseudocirrhosis Due to Desmoplastic Response to Chemotherapy in Breast Cancer Liver Metastases
por: Takata, Kazuhide, et al.
Publicado: (2022)

Multiple Ectopic Hepatocellular Carcinomas Arising in the Abdominal Cavity
por: Miyake, Toru, et al.
Publicado: (2012)

Lipopolysaccharides accelerate hepatic steatosis in the development of nonalcoholic fatty liver disease in Zucker rats
por: Fukunishi, Shinya, et al.
Publicado: (2014)

Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot study
por: Honda, Yasushi, et al.
Publicado: (2017)

Trends in hepatocellular carcinoma incident cases in Japan between 1996 and 2019
por: Nakano, Masahito, et al.
Publicado: (2022)

Predictors of hepatocellular carcinoma recurrence associated with the use of direct‐acting antiviral agent therapy for hepatitis C virus after curative treatment: A prospective multicenter cohort study
por: Nakano, Masahito, et al.
Publicado: (2019)

Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY)
por: Hirata, Takumi, et al.
Publicado: (2013)

Erratum to “Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY)”
por: Hirata, Takumi, et al.
Publicado: (2014)

Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
por: Imajo, Kento, et al.
Publicado: (2013)

Surveillance of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
por: Sumida, Yoshio, et al.
Publicado: (2020)

Development of Fibrosis in Nonalcoholic Steatosis through Combination of a Synthetic Diet Rich in Disaccharide and Low-Dose Lipopolysaccharides in the Livers of Zucker (fa/fa) Rats
por: Fukunishi, Shinya, et al.
Publicado: (2009)

Current Clinical Trial Status and Future Prospects of PPAR-Targeted Drugs for Treating Nonalcoholic Fatty Liver Disease
por: Kamata, Shotaro, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_k5jt5fibgkfq4ovvcrgs97tejd